Kyowa Kirin is a global specialty pharmaceutical company headquartered in Japan, dedicated to developing and delivering innovative medicines in areas with significant unmet needs, including bone and mineral disorders, hematologic malignancies, hematology-oncology, and rare diseases. With a mission centered on improving patient outcomes, Kyowa Kirin employs advanced biotechnologies and a comprehensive approach to drug discovery, development, and commercialization. Their commitment to making a positive impact on patients' lives is reflected in their collaborative culture and adherence to scientific rigor and ethical standards. In North America, the company operates from its headquarters in Princeton, NJ, along with additional locations in California, Massachusetts, and Ontario, providing a diverse range of opportunities for professionals interested in making a difference in the pharmaceutical industry.